Skip to main content
. 2016 Dec 15;5(4):333–342. doi: 10.3233/JHD-160200

Table 2.

Cholinergic-based treatments which have demonstrated beneficial effects in pre-clinical HD studies. Strength of evidence criteria was based on proper study design, number of subjects improved, level of improvement, lack of side effects and replication by others

Treatment Beneficial effect(s) Animal model Number of animals studied Reference(s) Strength of Comments
evidence
Donepezil improves cognitive function R6/2 transgenic mice First study: n = 73 (across 4 groups); second study: n = 55 (across 4 groups) [66] 8/10 Appropriate study design, appropriate mouse model, high number of mice used, results replicated in individual studies.
Galantamine reduces neurological deficits, striatal lesions and apoptosis 3-nitropropionic acid rat model n = 46 (across 5 groups) [69] 4/10 Appropriate study design although some groups with low numbers of mice, animal model used not ideal.
VU0467154 improves motor and synaptic function YAC128 transgenic mice Motor function: n = 41 (across 4 groups); synaptic function: n = 43 (across 4 groups) [85] 6/10 Appropriate study design, highly valid animal model used.
Physostigmine increases hippocampal cell proliferation Wistar rats n = 30 (across 5 groups) [79] 4/10 Animal model not HD-specific, relatively low numbers of animals.
Oxotremorine increases hippocampal cell proliferation, spatial working memory and reverses deficits in hippocampal neurogenesis Wistar rats n = 30 (across 5 groups) [79] 5/10 Multiple beneficial effects but animal model not HD-specific.
NGF improves motor and cognitive function; increases cholinergic cell survival, expression of ChAT, VAChT and trkA markers, hippocampal neurogenesis; reduces excitotoxicity and cholinergic cell atrophy R6/1 mice, YAC128 mice, Sprague-Dawley rats, Wistar rats R6/1 mice: n = 48 (across 4 groups); YAC128 mice: n = 64 (across 4 groups); SD rats study 1: n = 29 (across 4 groups); SD rats study 2: n = 27 (across 4 groups); SD rats study 3: n = 37 (across 4 groups); SD rats study 4: n = 18 (across 3 groups) [48, 87, 88, 90–95] 9/10 Appropriate study designs, valid animal models used, numerous beneficial effects reported, beneficial effects found by multiple research groups.
Wistar rats: n = 8 (across 2 groups)